Journal of Infection
Elsevier BV · GB · ISSN 01634453
动向摘要
More papers arrived and the journal's citedness rose noticeably.
Annual output went from 178 to 274 papers. Expect a busier table of contents with more brief reports and shorter studies. Field-weighted citation impact moved from 2.64 to 3.97. If you aim for visibility in citations, this venue now tends to attract more cited work. Streptococcal Infections and Treatments rose from 0.0% to 4.7% of what the journal runs. Authors working on streptococcal infections will find clearer topical fit than before. Gold open access accounts for 100.0%. Your article will be immediately available to all readers without paywall barriers.
引用指标
基于 Scopus 与 OpenAlex 引用图谱。本站不提供 Clarivate 的 JCR 影响因子。
发文量与被引表现
发文量增长时被引表现是否同步。
主题变化
对比近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)的占比。
- Streptococcal Infections and Treatments0.0%→4.7%+4.7%p此前近期
- Mosquito-borne diseases and control0.0%→4.7%+4.7%p此前近期
- Respiratory viral infections research6.0%→10.4%+4.4%p此前近期
- Bacterial Infections and Vaccines6.8%→10.1%+3.3%p此前近期
- Antibiotic Resistance in Bacteria3.5%→6.7%+3.2%p此前近期
- SARS-CoV-2 and COVID-19 Research29.5%→12.4%−17.1%p此前近期
- COVID-19 Clinical Research Studies7.5%→2.7%−4.8%p此前近期
- Long-Term Effects of COVID-194.3%→0.0%−4.3%p此前近期
- Diverse Scientific and Economic Studies3.8%→0.0%−3.8%p此前近期
近期高频术语
近期论文标题中相较以往显著增加的表述。
作者国家构成
将近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)并列显示。
- CN34.4%→30.2%−4.2%p此前近期
- GB22.6%→21.8%−0.8%p此前近期
- US14.7%→16.6%+1.9%p此前近期
- NL5.2%→6.9%+1.7%p此前近期
- AU4.8%→6.9%+2.1%p此前近期
- FR7.4%→6.7%−0.7%p此前近期
机构发文 Top 5
2018 – 2026 期间在该期刊发表论文的前 5 家机构。
近期发表论文
20按发表日期最新的 20 篇,并非全部。
高被引论文
202018 – 2026 期间被引最高的 20 篇。
相似期刊
数据截至 2026-09-05